Grinsztejn, B., Hughes, M. D., Ritz, J., Salata, R., Mugyenyi, P., Hogg, E., . . . Collier, A. C. (2019). Third-line antiretroviral therapy in low and middle income countries: ACTG A5288, a prospective strategy study. Lancet HIV.
Chicago Style CitationGrinsztejn, Beatriz, et al. "Third-line Antiretroviral Therapy in Low and Middle Income Countries: ACTG A5288, a Prospective Strategy Study." Lancet HIV 2019.
MLA CitationGrinsztejn, Beatriz, et al. "Third-line Antiretroviral Therapy in Low and Middle Income Countries: ACTG A5288, a Prospective Strategy Study." Lancet HIV 2019.
Warning: These citations may not always be 100% accurate.